Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease:

Safa Ahmadian, Don D Sin, Larry Lynd, Mark Harrison, Mohsen Sadatsafavi

14 October, 2022

NZ Respiratory Research Review Issue 204

Lifetime occupational exposures and chronic obstructive pulmonary disease risk in the UK Biobank cohort:

Sara De Matteis, Debbie Jarvis, Lucy Darnton, Dario Consonni, Hans Kromhout, Sally Hutchings, Steven S Sadhra, David Fishwick, Roel Vermeulen, Lesley Rushton, Paul Cullinan

16 September, 2022

NZ Respiratory Research Review Issue 204

Use of Singing for Lung Health as an alternative training modality within pulmonary rehabilitation for COPD: a randomised controlled trial:

Mette Kaasgaard, Daniel Bech Rasmussen, Karen Hjerrild Andreasson, Ole Hilberg, Anders Løkke , Peter Vuust and Uffe Bodtger

19 May, 2022

NZ Respiratory Research Review Issue 204

Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease:

Josefin Eklöf, Truls Sylvan Ingebrigtsen, Rikke Sørensen, Mohamad Isam Saeed, Imane Achir Alispahic, Pradeesh Sivapalan, Jonas Bredtoft Boel, Jette Bangsborg, Christian Ostergaard, Ram Benny Dessau, Ulrich Stab Jensen, Ejvind Frausing Hansen, Therese Sophie Lapperre, Howraman Meteran, Torgny Wilcke, Niels Seersholm, Jens-Ulrik Stæhr Jensen

17 May, 2022

NZ Respiratory Research Review Issue 204

Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease:

Charlotte Rigauts, Juliana Aizawa, Steven L. Taylor, Geraint B. Rogers, Matthias Govaerts, Paul Cos, Lisa Ostyn, Sarah Sims, Eva Vandeplassche, Mozes Sze, Yves Dondelinger, Lars Vereecke, Heleen Van Acker, Jodie L. Simpson, Lucy Burr, Anne Willems, Michael M. Tunney, Cristina Cigana, Alessandra Bragonzi, Tom Coenye and Aurélie Crabbé

5 May, 2022

NZ Respiratory Research Review Issue 204

Prognosis of Patients with Chronic Obstructive Pulmonary Disease Not Eligible for Major Clinical Trials:

Yunus Çolak, Børge G. Nordestgaard, Peter Lange, Jørgen Vestbo, and Shoaib Afzal

19 April, 2022

NZ Respiratory Research Review Issue 204

Prognosis of Patients with COPD Not Eligible for Major Clinical Trials:

Yunus Çolak; Børge G Nordestgaard; Peter Lange; Jørgen Vestbo; Shoaib Afzal

18 April, 2022

NZ Respiratory Research Review Issue 198

Optimizing COPD Acute Care Patient Outcomes Using a Standardized Transition Bundle and Care Coordinator - A Randomized Clinical Trial:

Chantal E. Atwood, PhD Mohit Bhutani, MD Maria B. Ospina, PhD Brian H. Rowe, MD Richard Leigh, MD Lesly Deuchar, MN Peter Faris, PhD Marta Michas, PhD Kelly J. Mrklas, PhD Jim Graham, RN Raymond Aceron, NP Ron Damant, MD Lee Green, MD Naushad Hirani, MD Kelly Longard, RN Virginia Meyer, MBA Patrick Mitchell, MD Willis Tsai, MD Brandie Walker, MD Michael K. Stickland, PhD

8 April, 2022

NZ Respiratory Research Review Issue 204

Health System Approach to Improve Chronic Obstructive Pulmonary Disease Care after Hospital Discharge: Stepped-Wedge Clinical Trial:

David H. Au, Margaret P. Collins, Douglas B. Berger, Paula G. Carvalho, Karin M. Nelson, Lynn F. Reinke, Richard B. Goodman, Rosemary Adamson, Deborah M. Woo, Peter J. Rise, Scott S. Coggeshall, Robert B. Plumley, Eric M. Epler, Brianna R. Moss, Jennifer A. McDowell, and William G. Weppner

25 March, 2022

NZ Respiratory Research Review Issue 204

Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis:

Davies Adeloye, PhD, Peige Song, PhD, Yajie Zhu, PhD, Prof Harry Campbell, MD, Prof Aziz Sheikh, MD Prof Igor Rudan, PhD et al.

10 March, 2022

NZ Respiratory Research Review Issue 198